Related posts
Weekly 52-Week Low (or 52-Week High): CM-T, GWO-T, BLDP-T, S-T and More 52-Week Highs and Lows (Aug 28-Sep 03)Mild gains and lossesTSX and Dow hit highsThis summary was created by AI, based on 6 opinions in the last 12 months.
MDA Ltd. is positioned as a global leader in the space economy with a strong backlog, impressive revenue and EBITDA growth projections, and recent addition to TSX Composite. The company has displayed solid momentum, strong cash flows, and has secured major contracts, leading to positive earnings and revenue visibility. Experts believe MDA is well positioned for continued growth and expansion in the satellite components market.
Recent winning of billion dollar space contract from Canadian government very profitable. Stock performing very well the past few years. Demand for products remains strong, at a profitable rate. Expecting further growth in the years to come. Stock price under valued in relation to peers. Would recommend holding for the long term investor.
Global tech leader, only pure-play public space technology. Cost of launching satellites has come way down. Well positioned in satellite systems, robotics, and geo-intelligence. $3.3B backlog. Clear visibility for 20-25% EBITDA growth per year for at least the next 3 years. Stock's come down to compellingly attractive levels.
It holds a dominant position in space technology. It also received a big contract with Telesat - more than $2 billion. It is a growth story.
Very strong company that is a leader within the space satellite sector. Capex investments are starting to payoff as cash flow begins to rise. Expecting company to win large government contracts. Runway for space exploration limitless. Excellent pick for long term investors.
Global leader in the field. There's a new "space" economy, and MDA is well positioned to capture a good share. $3B backlog. Clear visibility for 20% revenue and EBITDA growth per year for the next few years. Recently added to TSX Composite, underfollowed stock. 9x EBITDA, really cheap considering massive growth potential. No dividend.
(Analysts’ price target is $16.25)Forecasts call for sales growth of 23.5% and EPS growth of 21.1% in 2024. MDA has displayed nice momentum following a solid Q3 and has a large backlog of business. Additionally, MDA has started to see cash flows begin to increase. MDA is up 59% in the last year and a valuation of 17.9x forward earnings is decent considering the strong momentum in the last year and forecasted outlook. We are comfortable adding to MDA at the current levels.
Unlock Premium - Try 5i Free
The Telesat contract really kicked them up. (Telsat contracted MDA for a major project.) MDA was able to lower the costs which allowed Telesat to raise financing for their project. Happy to continue owning this.
Last week, the Telesat deal surprised everyone. Nobody saw it coming. MDA developed a technology that really dropped the costs, so they were able to raise the financing. That deal was a feather in the cap, but MDA's demand will grow anyway. He likes the story and is hanging on, not selling any shares.
EPS of 8c mostly matched estimates (8.2c); revenue of $196M was 1% better than expected. EBITDA of $40.4M was 11.5% better. Results were good, and guidance was raised. MDA also won a very large contract which adds significantly to earnings/revenue visibility. The stock has had a very big run; at 28X earnings it cannot be called cheap, but we think momentum can continue. We can't comment on position size but think it is buyable for aggressive investors, though we would not expect the same pace as recent gains.
Unlock Premium - Try 5i Free
He's been buying this all along. It bottomed at $6 and is now around $8.50. They're like the arms dealer in the old space race--making components in satellites. They're very well positioned. Are generating cash flow and raised full-year guidance. Delivered a good beat last quarter. Their valuation will expand. Satellites will continue to launch so there will be demand.
Arms dealers of the space race. So well positioned, great growth profile. 20% annualized growth rate. In a growth area, and these guys make the nuts and bolts. Decent valuation, positive free cashflow. No dividend.
(Analysts’ price target is $10.50)Still likes it despite the disappointment. Haven't missed numbers. They're still expecting 25% cashflow growth over the next 3-4 years. Potential for takeout.
MDA Ltd. is a Canadian stock, trading under the symbol MDA-T on the Toronto Stock Exchange (MDA-CT). It is usually referred to as TSX:MDA or MDA-T
In the last year, 5 stock analysts published opinions about MDA-T. 5 analysts recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for MDA Ltd..
MDA Ltd. was recommended as a Top Pick by on . Read the latest stock experts ratings for MDA Ltd..
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
5 stock analysts on Stockchase covered MDA Ltd. In the last year. It is a trending stock that is worth watching.
On 2024-09-11, MDA Ltd. (MDA-T) stock closed at a price of $15.25.
His top pick in the past. This offers rare growth in the industrial space. Expects 25% earnings cash flow growth over 5 years and likely a 8x cash flow.